At a ratio of 1 : 2 and 1 : 1 Tregs : PBMCs, the inhibition of CD154 expression on CD4+ effector cells was reduced in stroke patients compared to healthy controls (p < 0.0001) (Figure 4(b)). Here, CD4 is linked to Stroke.